Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Boston Scientific Corporation
Summary
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Description
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU). * Signed a valid, IRB/EC-approved informed consent form. Exclusion Criteria: * Meets any contraindications per locally applicable Instructions for Use (IFU).
Interventions
- DeviceIntracept™ Intraosseous Nerve Ablation
Intracept™ Intraosseous Nerve Ablation for treatment of patients diagnosed with vertebrogenic pain
Locations (16)
- Flagstaff Bone & JointFlagstaff, Arizona
- Innovative Pain and WellnessPhoenix, Arizona
- MarinHealth Spine InstituteLarkspur, California
- The Spine Wellness Center in WestportWestport, Connecticut
- Washington Hospital CenterWashington D.C., District of Columbia
- North Idaho Day Surgery, LLCPost Falls, Idaho